Estrogen Replacement and Atherosclerosis (ERA) in Older Women
Status:
Completed
Trial end date:
2000-07-01
Target enrollment:
Participant gender:
Summary
To determine if estrogen replacement therapy, with or without low dose progesterone, slows
progression or induces regression of coronary atherosclerosis in postmenopausal women.